These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10970927)

  • 1. Effects of divalproex versus lithium on length of hospital stay among patients with bipolar disorder.
    Dalkilic A; Diaz E; Baker CB; Pearsall HR; Woods SW
    Psychiatr Serv; 2000 Sep; 51(9):1184-6. PubMed ID: 10970927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
    Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
    J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of divalproex versus lithium.
    Baker CB; Woods SW; Sernyak MJ
    J Clin Psychiatry; 1997 Aug; 58(8):363-4. PubMed ID: 9515977
    [No Abstract]   [Full Text] [Related]  

  • 4. The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay.
    Frye MA; Altshuler LL; Szuba MP; Finch NN; Mintz J
    J Clin Psychiatry; 1996 Jan; 57(1):17-21. PubMed ID: 8543542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacoeconomic model of divalproex vs. lithium in the acute and prophylactic treatment of bipolar I disorder.
    Keck PE; Nabulsi AA; Taylor JL; Henke CJ; Chmiel JJ; Stanton SP; Bennett JA
    J Clin Psychiatry; 1996 May; 57(5):213-22. PubMed ID: 8626353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylactic long-term therapy of affective disorders with lithium, valproic acid and carbamazepine--effectiveness and cost-effectiveness].
    Roick C; Ahrens B; Becker T
    Psychiatr Prax; 2001 Jul; 28 Suppl 1():S32-40. PubMed ID: 11533905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is divalproex a cost-effective alternative in the acute and prophylactic treatment of bipolar I disorder?
    Dardennes RM; Even C
    J Clin Psychiatry; 1997 Nov; 58(11):495-6. PubMed ID: 9413417
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacoeconomic and health outcome comparison of lithium and divalproex in a VA geriatric nursing home population: influence of drug-related morbidity on total cost of treatment.
    Conney J; Kaston B
    Am J Manag Care; 1999 Feb; 5(2):197-204. PubMed ID: 10346515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trial.
    Zhu B; Tunis SL; Zhao Z; Baker RW; Lage MJ; Shi L; Tohen M
    Curr Med Res Opin; 2005 Apr; 21(4):555-64. PubMed ID: 15899104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
    Yatham LN; Vieta E; Young AH; Möller HJ; Paulsson B; Vågerö M
    Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of quetiapine with lithium or divalproex for maintenance treatment of bipolar I disorder.
    Woodward TC; Tafesse E; Quon P; Kim J; Lazarus A
    J Med Econ; 2009; 12(4):259-68. PubMed ID: 19769548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.
    Kowatch RA; Suppes T; Carmody TJ; Bucci JP; Hume JH; Kromelis M; Emslie GJ; Weinberg WA; Rush AJ
    J Am Acad Child Adolesc Psychiatry; 2000 Jun; 39(6):713-20. PubMed ID: 10846305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania.
    Swann AC; Bowden CL; Calabrese JR; Dilsaver SC; Morris DD
    Neuropsychopharmacology; 2002 Apr; 26(4):530-6. PubMed ID: 11927177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placebo.
    Bowden CL; Collins MA; McElroy SL; Calabrese JR; Swann AC; Weisler RH; Wozniak PJ
    Neuropsychopharmacology; 2005 Oct; 30(10):1932-9. PubMed ID: 15956987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of lurasidone as an adjunct to lithium or divalproex in the treatment of bipolar disorder.
    Alamo C; López-Muñoz F; García-García P
    Expert Rev Neurother; 2014 Jun; 14(6):593-605. PubMed ID: 24779382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].
    Dardennes R; Lafuma A; Watkins S
    Encephale; 1999; 25(5):391-400. PubMed ID: 10598301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute inpatient treatment, hospitalization course and direct costs in bipolar patients with intellectual disability.
    Wu CS; Desarkar P; Palucka A; Lunsky Y; Liu SK
    Res Dev Disabil; 2013 Nov; 34(11):4062-72. PubMed ID: 24051362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suicide risk in bipolar disorder during treatment with lithium and divalproex.
    Goodwin FK; Fireman B; Simon GE; Hunkeler EM; Lee J; Revicki D
    JAMA; 2003 Sep; 290(11):1467-73. PubMed ID: 13129986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania.
    Swann AC; Bowden CL; Calabrese JR; Dilsaver SC; Morris DD
    Am J Psychiatry; 1999 Aug; 156(8):1264-6. PubMed ID: 10450271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials.
    Suppes T; Vieta E; Gustafsson U; Ekholm B
    Depress Anxiety; 2013 Nov; 30(11):1089-98. PubMed ID: 23761037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.